Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystr…
Biotechnology
US, Boulder [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Edgewise Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Edgewise Therapeutics, Inc. has no acquisition track records yet.